Class II · Moderate risk
Cytarabine 128 MG/250 ML D5W IVPB
Lack of Assurance of Sterility
Is Cytarabine recalled?
Not under an active recall.
Cytarabine was recalled 4 times in the past — all now closed. Most recent: Jun 12, 2019.
Most common reason: Particulate / foreign matter (2 of these recalls)
Recalls are matched by product description. A recall usually affects specific lots, not every package of Cytarabine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
Cytarabine recalls on record
none so far in 2026; 4 on record, newest first
Class I · High risk
Cytarabine Injection 100 mg/5 mL
Presence of Particulate Matter
Class II · Moderate risk
CYTARAbine for Injection USP
Lack of Assurance of Sterility: Crimp defects during visual inspection could affect container closure integrity.
Class II · Moderate risk
Cytarabine Injection
The affected lots of Carboplatin Injection, Cytarabine Injection, Methotrexate Injection, USP, and Paclitaxel Injection are being recalled due to visible particles embedded in the glass located at the neck of the vial. There may be the potential for product to come into contact with the embedded particles and the particles may become dislodged into the solution.
Free recall alerts
Know the day your medication is recalled
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.